Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,306 INR | +0.26% | +1.27% | -3.62% |
24/05 | Caplin Point Arm Gets US FDA's Nod for Phenylephrine Hydrochloride Ophthalmic Solution | MT |
16/05 | Caplin Point Laboratories to Seek Acquisitions | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.62% | 1.19B | |
+17.47% | 42.95B | |
+16.32% | 21.38B | |
+19.25% | 15.05B | |
+18.82% | 14.45B | |
+54.40% | 13.04B | |
-0.05% | 6.79B | |
-12.64% | 6.72B | |
-8.87% | 5.73B | |
+11.21% | 5.47B |
- Stock Market
- Equities
- CAPLIPOINT Stock
- News Caplin Point Laboratories Limited
- Transcript : Caplin Point Laboratories Limited, Q2 2021 Earnings Call, Nov 06, 2020